The brain fog, the heaviness that doesn’t resemble a lack of sleep, the distance from oneself: depression often manifests as a disrupted biological terrain, not just a simple brain malfunction.
For decades, the official narrative has focused primarily on brain chemistry and molecules. Antidepressants, therapy, and well-intentioned advice have their place. However, the inflamed gut, declining cellular energy, and the connection between gut microbiota and mood remain absent from public discourse.
What the body expresses may be a coherent signal, not an isolated mental dysfunction.
The Brain Is Not Alone
When examining current research, a picture emerges: an exhausted, inflamed organism with disrupted internal communication systems.
Mood is often linked to neurotransmitters produced in the brain. Serotonin is the most cited example, especially in the context of antidepressants. About 95% of the body’s serotonin is produced in the gut, where it primarily regulates motility and digestive secretion, not mood.
This peripheral serotonin does not cross the blood-brain barrier. The brain produces its own serotonin from a shared amino acid, tryptophan.
When the intestinal lining becomes inflamed and the gut flora becomes imbalanced, inflammation diverts tryptophan away from the serotonergic pathway towards kynurenine.
The brain’s raw material becomes scarce. This link between tryptophan diversion and inflammation is one of the most well-documented mechanisms by which the gut influences mood: alongside the vagus nerve, microbial metabolites, and immune signaling; it is not the intestinal serotonin itself that directly fuels the brain.
This gut-brain connection forms a biological highway, the gut-brain axis: a bidirectional communication network between the digestive system and the central nervous system. When this axis is disrupted, the consequences affect mood, motivation, and the ability to feel pleasure.
The Silent Inflammation That Dulls Energy
Depression rarely comes alone. It is often accompanied by chronic fatigue, diffuse pain, sleep disturbances, and concentration difficulties.
These symptoms are not coincidences. They share a common root: chronic neuroinflammation.
In a state of low-grade, prolonged, and silent inflammation, the brain reacts. Pro-inflammatory cytokines, molecules produced by the immune system in response to aggression, influence the brain through several communication pathways between the immune system and the central nervous system, gradually altering brain chemistry. They slow the production of dopamine, serotonin, and norepinephrine.
This diversion of tryptophan towards the kynurenine pathway intensifies, increasing the production of certain metabolites associated with anxiety, depression, and neuroinflammation, to the detriment of cerebral serotonin. The brain then operates in a hostile biological environment.
Exhausted Mitochondria
Behind this inflammation, another signal appears: cellular energy collapse. The mitochondria, small energy powerhouses present in every cell, are on the front line.
When they malfunction, the body produces less ATP, the molecule that fuels vital functions. Less energy available, fewer neurotransmitters produced, less cellular repair, less capacity to respond to stress.
What research observes in people suffering from depression is often measurable mitochondrial dysfunction. Cells no longer produce energy efficiently. They shift to degraded modes, generating more inflammatory waste and less usable energy.
The brain consumes about 20% of the body’s total energy for 2% of body weight. It is particularly vulnerable to this deficit. When energy is lacking, higher cognitive functions, mood, and motivation are the first to collapse.
Sugar and Insulin, the Invisible Actors
Another thread connects these mechanisms: metabolic deregulation. A diet chronically high in carbohydrates keeps insulin elevated, day after day, meal after meal.
This chronic hyperinsulinemia, meaning an abnormally high insulin level over a prolonged period, affects not only weight or diabetes risk. It also affects the brain.
Insulin plays a role in regulating serotonin, dopamine, and neuronal plasticity. When insulin receptors in the brain become resistant, saturated by years of excessive exposure, the brain loses some of its ability to adapt, learn, and regulate mood.
Prospective studies describe an established link between insulin resistance and depression risk, moderate but reproducible; the causative direction remains debated.
The brain can function with glucose, but also with ketone bodies, molecules produced by the liver when carbohydrate intake is low. Ketone bodies are a more stable, less inflammatory energy source; they activate pathways that protect neurons, reduce brain inflammation, and improve mitochondrial function.
When the brain receives ketones instead of being bombarded with glucose and insulin in rollercoaster fashion, it regains energy stability. Preliminary clinical studies, mostly conducted in bipolar or schizophrenic patients and always as a treatment complement, report real psychiatric improvements under nutritional ketosis.
The Terrain, Not the Symptom
In this perspective, depression becomes an indicator of a disturbed biological terrain: inflamed intestines, exhausted mitochondria, a brain deprived of stable energy, an immune system on constant alert. Research connects these mechanisms: microbiota, inflammation, insulin resistance, mitochondrial exhaustion. It begins to measure them: elevated inflammatory markers, reduced microbial diversity, disrupted metabolic profiles.
Studies test nutritional interventions and document mood improvements when inflammation decreases, when the microbiota rebalances, when carbohydrate intake drops, and when energy metabolism stabilizes. These data remain to be confirmed on a larger scale, but they converge: depression is less read as an isolated brain disease than as the trace of a systemic imbalance.
Taking Control
One can begin to observe this terrain without waiting for a perfect medical protocol to be validated: digestive disorders associated with mood, worsening after certain meals, coincidence with intense fatigue or mental fog.
Research documents that reducing carbohydrate intake, favoring quality fats, nourishing the microbiota with unprocessed foods, getting enough sleep, and moving regularly can influence inflammation, mitochondrial function, and neurotransmitter production. These are concrete biological levers.
Depression presents itself as a coherent response to a disturbed terrain. And a terrain can be changed.
DISCLAIMER: This article is for informational purposes only and does not replace personalized medical advice. The dietary choices described here are based on documented anthropological and biological data, but any change to your diet, especially in the presence of medical conditions or ongoing treatment, should be discussed with a qualified healthcare professional. These approaches complement medical follow-up; they never replace psychiatric treatment. Any change in treatment (especially stopping an antidepressant) must be done with a physician, never on your own.
Sources and References
-
* Miller AH et al. The role of inflammation in depression: from evolutionary imperative to modern treatment target. — Inflammation and Depression — Mechanistic Review
-
* Marx W et al. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies. — Kynurenine Pathway, Tryptophan Diversion and Depression
-
* Bansal Y et al. Mitochondrial Dysfunction in Depression. — Mitochondria and Depression
-
* Limbana T et al. Gut Microbiome and Depression: How Microbes Affect the Way We Think. — Microbiome and Inflammation in Depression
-
* Watson KT et al. Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study. — Insulin Resistance and Depression Risk
-
* Sethi S et al. Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial. — Nutritional Ketosis and Psychiatric Health